Affymax, Inc. (AFFY)

Market Cap	74.49K -75.0%
Revenue (ttm)	42.00K -99.9%
Net Income	3.07M
EPS	0.08
Shares Out	74.49M
PE Ratio	0.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	15,206
Open	0.0010
Previous Close	n/a
Day's Range	0.0010 - 0.0010
52-Week Range	0.0001 - 0.0030
Beta	8.27
RSI	50.60
Earnings Date	n/a

About Affymax

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: AFFY

Financial Performance

In 2013, Affymax's revenue was $1.37 million, a decrease of -98.55% compared to the previous year's $94.37 million. Losses were -$14.42 million, -84.56% less than in 2012.